InsiderTrades

Form 4 for DTIL PRECISION BIOSCIENCES INC

Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001209191-23-020716 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-23 2023-03-22 DTIL Amoroso Michael Pres, CEO, Dir S - Sale+OE $0.82 -47.0K 68.7K -41% -$38.5K
D 2023-03-23 2023-03-21 DTIL Amoroso Michael Pres, CEO, Dir M - OptEx — +102.5K 115.7K +777% —
D 2023-03-23 2023-03-21 DTIL Amoroso Michael Pres, CEO, Dir M - OptEx $0.00 -102.5K 205.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-22 S D 46,999 $0.82 68,738 D — —
2 Common Common Stock 2023-03-21 M A 102,535 — 115,737 D — — (F1) Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 21, 2023. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
3 Derivative Restricted Stock Units 2023-03-21 M D 102,535 $0.00 205,009 D — · — to — 102,535 Common Stock (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F4) On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.